AMAG Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application (sNDA) for Feraheme® (ferumoxytol injection)

World News: . []

WALTHAM Mass Feb 05 2018 GLOBE NEWSWIRE -- AMAG Pharmaceuticals Inc NASDAQAMAG today announced that the US Food and Drug Administration FDA has approved its application to broaden the existing label for Feraheme ferumoxytol inject ion) be...

More news and information about AMAG Pharmaceuticals, Inc.

Published By:

Globe Newswire: 13:00 GMT Monday 5th February 2018

Published: .

Search for other references to "amag" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us